Vimarsana
Biggest News Aggregation in the World

Bart Cornelissen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bart Cornelissen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bart Cornelissen Today - Breaking & Trending Today

Meet Scribd Inc.'s new CEO: Tony Grimminck was promoted from his role of CFO - Vimarsana News

Meet Scribd Inc.'s new CEO: Tony Grimminck was promoted from his role of CFO

The chief executive discusses what prepared him for the job.

The Escalator: Bayer, Stevanato Group, Qnovia and more - Vimarsana News

The Escalator: Bayer, Stevanato Group, Qnovia and more

See which leaders are on the move across the pharma, biotech and medical marketing industries.

Fortune just named its first female CEO. Here's how serving as CFO at the 95-year-old media titan helped her prepare - Vimarsana News

Fortune just named its first female CEO. Here's how serving as CFO at the 95-year-old media titan helped her prepare

Anastasia Nyrkovskaya joined Fortune in 2019 as finance chief and later added the role of chief strategy officer.

Xencor Appoints Bart Cornelissen as Chief Financial Officer - Vimarsana News

Xencor Appoints Bart Cornelissen as Chief Financial Officer

Xencor, Inc. , a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, today announced the appointment of Bart Cornelissen...

Erasmus University Rotterdam joins forces with researchers from Erasmus MC and TU Delft to work on sustainable healthcare - Vimarsana News

Erasmus University Rotterdam joins forces with researchers from Erasmus MC and TU Delft to work on sustainable healthcare

The new sustainable programmes are SMART OR2023, Technological Innovations for Nurses, and Transition towards Zero Emission Endoscopy. They will receive €200,000 annually for four years from Erasmus MC to work on sustainable healthcare solutions. The programs were selected by Convergence Health & Technology, the collaboration between TU Delft innovators, Erasmus MC clinicians and EUR sociologists and economists.